Riyadh — Mubasher: Twareat Medical Care Company has issued a formal disclosure regarding the latest developments in its ongoing legal proceedings against Saudi Basic Industries Corporation (SABIC).
The Court of Appeal has reached a decision concerning the litigation, marking a significant milestone in a case that has been closely monitored by shareholders and market observers since its initial filing.
According to the regulatory filing, the Court of Appeal has officially issued a verdict that upholds the judgment previously rendered by the Court of First Instance.
By affirming the lower court’s decision in its entirety, the appellate ruling reinforces the legal position established during the preliminary stages of the litigation.
This update serves as a follow-up to the company’s previous announcement made on the Saudi Exchange (Tadawul) website on 6 October 2026.
The confirmation of the ruling by the Court of Appeal is expected to have a tangible effect on the company’s fiscal performance.
Twareat Medical Care Company stated in its disclosure that it anticipates a positive financial impact resulting from this judicial outcome. This impact is projected to be reflected in the company’s financial results for the fourth quarter (Q4) of 2026 .
The management noted that there have been no delays in the legal process relative to the previously announced timelines, and the company has not reported any additional costs or changes in expenses associated with this specific legal event.
From a reporting perspective, the company clarified that the progression of this case has not caused any delays in the preparation or publication of its periodic financial statements.
The anticipated positive contribution to the fourth-quarter results aligns with the company’s broader financial planning and disclosure obligations under the Capital Market Authority’s (CMA) regulations.